Healing of articular cartilage defects treated with a novel drug-releasing rod-type implant after microfracture surgery

Journal of Controlled Release

Volumn 129, Issue 3, 2008, Pages 187-191

  Shim, In Kyong ^a   Yook, Yeo Joo ^a   Lee, Sang Young ^b   Lee, Sang Hoon ^b   Park, Ki Dong ^c   Lee, Myung Chul ^b   Lee, Seung Jin ^a  

^a Ewha Womans University   (South Korea)

^b Seoul National University   (South Korea)

^c Ajou University   (South Korea)

Author keywords

Controlled release; DHEA S; Microfracture surgery; Rod type implant

Indexed keywords

CHEMOTHERAPY; CONTROLLED DRUG DELIVERY; DRUG DELIVERY; DRUG DOSAGE; HEALTH; LIGAMENTS; NANOSTRUCTURED MATERIALS; ORGANIC POLYMERS; SULFATE MINERALS; SURGERY; TISSUE ENGINEERING; ULTRASONIC MEASUREMENT;

ARTICULAR CARTILAGE (AC); ARTICULAR CARTILAGE DEFECTS; BURST RELEASE; CARTILAGE REGENERATION; CLINICAL OUTCOME; CONTROLLED RELEASES; DEHYDROEPIANDROSTERONE (DHEA); MICRO FRACTURING; POLY(D ,L-LACTIC ACID-CO-GLYCOLIC ACID) (PLGA); RABBIT KNEES; REGENERATED CARTILAGE; TRI-CALCIUM-PHOSPHATE (TCP);

CARTILAGE;

CALCIUM PHOSPHATE; POLYGLACTIN; POLYMER; PRASTERONE SULFATE;

ANIMAL EXPERIMENT; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; IMPLANT; IMPLANTATION; KNEE; MICROFRACTURE SURGERY; NONHUMAN; ORTHOPEDIC SURGERY; PRIORITY JOURNAL; RABBIT; TISSUE REGENERATION; WOUND HEALING;

ANIMALS; BUFFERS; CALCIUM PHOSPHATES; CARTILAGE, ARTICULAR; CHLOROFORM; COLORING AGENTS; COMPRESSIVE STRENGTH; DEHYDROEPIANDROSTERONE SULFATE; DRUG IMPLANTS; FRACTURES, CARTILAGE; HYDROGEN-ION CONCENTRATION; LACTIC ACID; METHYLENE CHLORIDE; MOLECULAR WEIGHT; ORTHOPEDIC PROCEDURES; PHENAZINES; PHOSPHATES; POLYGLYCOLIC ACID; POWDERS; PROSTHESES AND IMPLANTS; RABBITS; SOLVENTS; TEMPERATURE; TIME FACTORS; VISCOSITY; WOUND HEALING;

EID: 48949115539     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.04.003     Document Type: Article

References (25)

1. Buckwalter J., Rosenberg L., and Hunziker E. Articular Cartilage: Composition, Structure, Response to Injury, and Methods of Facilitating Repair (1990), New York, Raven Press Ltd.
2. Johson L.L. Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthoscopy 2 (1986) 54-69
3. Pridies K.H. A method of resurfacing osteoarthritic knee joints. J. Bone Joint Surg. [Br] 41 (1959) 618-619
4. Rodrigo J.J., Steadman J.R., Silliman J.F., and Fulstone H.A. Improvement of full-thickness chondral defect healing in the human knee after debridement and microfracture using continuous passive motion. Am. J. Knee Surg. 7 (1994) 109-116
5. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., and Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocytes transplantation. N. Engl. J. Med. 331 (1994) 889-895
6. Steadman J.R., Briggs K.K., Rodrigo J.J., Kocher M.S., Gill T.J., and Rodkey W.G. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-sup. Arthroscopy 19 (2003) 477-484
7. Sledge S.L. Osteochondral injuries of the knee - microfracture techniques in the treatment of osteochondral injuries. Clin. Sports Med. 20 (2001) 365-377
8. Frisbie D.D., Oxford J.T., Southwood L., Trotter G.W., Rodkey W.G., Steadman J.R., Goodnight J.L., and McIlwraith C.W. Early events in cartilage repair after subchondral bone microfracture. Clin. Orthop. Relat. Res. 407 (2003) 215-227
9. Mitchell N., and Shepard N. The resurfacing of adult rabbit articular cartilage by multiple perforations through the subchondral bone. J. Bone Joint Surg., Am. 58 (1976) 230-233
10. Hornsby P.J. DHEA: a biologist's perspective. J. Am. Geriatr. Soc. 45 (1997) 1395-1401
11. Alexandersen P., Harrabo J., and Christiansen C. The relationship of natural androgen to coronary heart disease in males: a review. Atherosclerosis 125 (1996) 1-14
12. Zumoff B., Levin J., Rosenfeld R.S., Markham M., Strain G.W., and Fukushima D.K. Abnormal 24-hr mean plasma concentrations of dehydroisoandrosterone and dehydroisoandrosterone sulfate in women with primary operable breast cancer. Cancer Res. 41 (1981) 3360-3363
13. Coleman D.L., Schwizer R.W., and Leiter E.H. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice. Diabetes 33 (1984) 26-32
14. Barrett-Conner E., and Ferrara A. Dehydroepiandrosteron, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and non-insulin dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 81 (1996) 59-64
15. Watson R.R., Hulls A., Araghi-Niknam M., and chung S. Dehydroepiandrosterone (DHEA) supplementation to prevent symptoms of aging. Drugs Aging 9 (1996) 274-291
16. Mirone L., Altomonte L., D P., ' Agostino, Zoli A., Barini A., and Magaro M. A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis: correlation with disease activity. Clin. Rheumatol. 15 (1996) 15-19
17. Masi A.T., and Chrousos G.P. Hypothalamic-pituitary-adrenal-glucocoricoid axis functioning rheumatoid arthritis. J. Rhematol. 23 (1996) 577-581
18. De la Torre B., Hedman M., Nilsson E., Olesen O., and Thorner A. Relationship between blood and joint tissue DHEAS levels in rheumatoid arthritis and osteoarthritis. Clin. Exp. Rheumatol. 11 (1993) 597-601
19. Jo H., Park J.S., Kim E.M., Jung M.Y., Lee S.H., Seong S.C., Park S.C., Kim H.J., and Lee M.C. The in vitro effects of dehydroepiandrosterone on human osteoarthritic chondrocytes. Osteoarthr. Cartil. 11 (2003) 585-594
20. Holland T.A., and Mikos A.G. Advances in drug delivery for articular cartilage. J. Control. Release 86 (2003) 1-14
21. L.M. Ehrenfried, M.H. Patel, R.E. Cameron, The effect of tri-calcium phosphate (TCP) addition on the degradation of polylactide-co-glycolide (PLGA), J. Mater. Sci., Mater. Med. (in press).
22. Lin F., Chen T., Lin C., and Lee C. The merit of sintered PDLLA/TCP composites in management of bone fracture internal fixation. Artif. Organs 23 2 (1999) 186-194
23. Ginebra M.P., Traykova T., and Planell J.A. Calcium phosphate cements as bone drug delivery systems: a review. J. Control. Release 113 (2006) 102-110
24. Soriano I., and Evora C. Formulation of calcium phosphates/poly(d,l-lactide)blends containing gentamicin for bone implantation. J. Control. Release 68 (2000) 121-134
25. Jo H., Ahn H.J., Kim E.M., Kim H.J., Seong S.C., Lee I.B., and Lee M.C. Effects of dehydroepiandrosterone on articular cartilage during the development of osteoarthritis. Arthritis Rheum. 50 (2004) 2531-2538